Overview

Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects

Status:
Completed
Trial end date:
2021-01-15
Target enrollment:
Participant gender:
Summary
This study will investigate the tolerability and pharmacokinetics of Hypidone Hydrochloride by multiple doses in 36 healthy male and female subjects who are of 18 to 55 years old.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.